270 related articles for article (PubMed ID: 34075005)
1. Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study.
Permpalung N; Bazemore K; Chiang TP; Mathew J; Barker L; Nematollahi S; Cochran W; Sait AS; Avery RK; Shah PD
Transplantation; 2021 Sep; 105(9):2072-2079. PubMed ID: 34075005
[TBL] [Abstract][Full Text] [Related]
2. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
[TBL] [Abstract][Full Text] [Related]
3. Human Metapneumovirus and Parainfluenza Virus Infections in Lung Transplant Recipients: The Effects on Lung Allograft and Clinical Outcomes.
Permpalung N; Sait AS; Bazemore K; Avery RK; Mathew J; Shah PD
Transplantation; 2021 Dec; 105(12):2625-2631. PubMed ID: 33496558
[TBL] [Abstract][Full Text] [Related]
4. Simkania negevensis and acute cellular rejection in lung transplant recipients.
Jamal AJ; Resende MR; Prochnow T; McGilvray I; Pilewski JM; Crespo MM; Singer LG; McCurry KR; Kolls JK; Keshavjee S; Liles WC; Husain S
Clin Transplant; 2015 Aug; 29(8):705-11. PubMed ID: 26009941
[TBL] [Abstract][Full Text] [Related]
5. Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center study.
Shah SZ; Abdelmoneim Y; Pham SM; Elrefaei M
Hum Immunol; 2022 Nov; 83(11):749-754. PubMed ID: 35987702
[TBL] [Abstract][Full Text] [Related]
6. Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.
Ensor CR; Yousem SA; Marrari M; Morrell MR; Mangiola M; Pilewski JM; D'Cunha J; Wisniewski SR; Venkataramanan R; Zeevi A; McDyer JF
Am J Transplant; 2017 May; 17(5):1380-1388. PubMed ID: 28173620
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipients.
Trindade AJ; Chapin KC; Gannon WD; Hoy H; Demarest CT; Lambright ES; McPherson KA; Norfolk SG; Robbins IM; Bacchetta M; Erasmus DB; Shaver CM
Transpl Infect Dis; 2022 Dec; 24(6):e13967. PubMed ID: 36271645
[TBL] [Abstract][Full Text] [Related]
8. Association of TNF-α, TGF-β1, IL-10, IL-6, and IFN-γ gene polymorphism with acute rejection and infection in lung transplant recipients.
Mu HJ; Xie P; Chen JY; Gao F; Zou J; Zhang J; Zhang B
Clin Transplant; 2014 Sep; 28(9):1016-24. PubMed ID: 24974875
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in lung transplant recipients: A single center case series from New York City.
Aversa M; Benvenuto L; Anderson M; Shah L; Robbins H; Pereira M; Scheffert J; Carroll M; Hum J; Nolan M; Reilly G; Lemaitre P; Stanifer BP; D'Ovidio F; Sonett J; Arcasoy S;
Am J Transplant; 2020 Nov; 20(11):3072-3080. PubMed ID: 32881315
[TBL] [Abstract][Full Text] [Related]
10. The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.
Levy L; Huszti E; Tikkanen J; Ghany R; Klement W; Ahmed M; Husain S; Fiset PO; Hwang D; Keshavjee S; Singer LG; Juvet S; Martinu T
Am J Transplant; 2020 Jan; 20(1):241-249. PubMed ID: 31397939
[TBL] [Abstract][Full Text] [Related]
11. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study.
Chaudhry ZS; Williams JD; Vahia A; Fadel R; Parraga Acosta T; Prashar R; Shrivastava P; Khoury N; Pinto Corrales J; Williams C; Nagai S; Abouljoud M; Samaniego-Picota M; Abreu-Lanfranco O; Del Busto R; Ramesh MS; Patel A; Alangaden GJ
Am J Transplant; 2020 Nov; 20(11):3051-3060. PubMed ID: 32654332
[TBL] [Abstract][Full Text] [Related]
14. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection.
Sayah DM; Koff JL; Leard LE; Hays SR; Golden JA; Singer JP
Clin Transplant; 2013; 27(1):E64-71. PubMed ID: 23278569
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 social distancing measures on lung transplant recipients: decline in overall respiratory virus infections is associated with stabilisation of lung function.
de Zwart AES; Riezebos-Brilman A; Lunter GA; Neerken ECU; van Leer-Buter CC; Alffenaar JC; van Gemert AP; Erasmus ME; Gan CT; Kerstjens HAM; Vonk JM; Verschuuren EAM
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35896214
[TBL] [Abstract][Full Text] [Related]
16. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
[TBL] [Abstract][Full Text] [Related]
17. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
[TBL] [Abstract][Full Text] [Related]
18. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
